COVID‐19 associated EBV reactivation and effects of ganciclovir treatment
Mei Meng(Shanghai Jiao Tong University), Dechang Chen(Shanghai Jiao Tong University), Djillali Annane(Université Paris-Saclay), Zhixiong Wu(Fudan University), Yunfeng Deng(Shandong Chest Hospital), Ranran Li(Shandong University), Sheng Zhang(Shanghai Jiao Tong University), Xuan Dong(The Ohio State University), Wenzhe Li(Peking University), Wenqing Sun(Hsin Sheng College of Medical Care and Management)
Cited by 59
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k